Promethazine
Promethazine is a first-generation antihistamine used to relieve allergy symptoms, nausea, vomiting, and motion sickness, and to provide sedation before or after certain medical procedures. It works primarily by blocking histamine H1 receptors and also has anticholinergic effects that help reduce nausea and motion-related symptoms. It is available in formulations such as oral tablets, syrups, suppositories, and injections, depending on the country and intended use. Common side effects include drowsiness, dizziness, dry mouth, blurred vision, and constipation. Important risks include respiratory depression, particularly in young children and when combined with opioids or other sedatives, as well as confusion and low blood pressure. Promethazine injection can cause severe tissue injury if improperly administered. It should be used according to medical guidance, and it must not be given to children under two years of age.
Promethazine was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Promethazine, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Promethazine from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Promethazine, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
